Board reasoning
The Board remands for an addendum medical opinion from a oncology-qualified examiner to determine whether there was local recurrence or metastasis at the time of the July 2016 examination, and to address specific proffered findings and treatment notes. The opinion must review the full claims file, discuss the appellant's arguments, and provide a comprehensive rationale, clarifying whether any cancer activity could be linked to the 2016 examination and acknowledging incorrect or conflicting medical records found in the file.
Issues
- Reduction in the rating of B-cell lymphoma from 100 percent to noncompensable, effective March 1, 2017Remanded
Extracted with gpt-5-nano-2025-08-07. Citations are kept only when they appear in the decision text.